TY - JOUR
T1 - Evaluation of EU legislation on blood
T2 - A bioethical point of view
AU - Petrini, Carlo
PY - 2017/11/9
Y1 - 2017/11/9
N2 - A review of the European Union (EU) regulations concerning blood, tissues, and cells of human origin is under way in the EU. From the ethical point of view, the non-remuneration of donations and the ban on deriving gain from human biological materials are of particular significance. While the basic ethical principles involved in the procurement, preservation, and use of these materials are the same, their practical application should be adapted to the specific context of each material. In the case of donation and use of blood, in particular, the issue of legitimate reimbursements to donors and for transfusion centers has to be managed in accordance with the principle of non-commercialization. There is also a need for strict rules to avoid possible commercial spillover effects from blood-derived products. The author proposes ethical criteria regarding reimbursements to donors, costs associated with processing, and the development (and possible marketing) of products.
AB - A review of the European Union (EU) regulations concerning blood, tissues, and cells of human origin is under way in the EU. From the ethical point of view, the non-remuneration of donations and the ban on deriving gain from human biological materials are of particular significance. While the basic ethical principles involved in the procurement, preservation, and use of these materials are the same, their practical application should be adapted to the specific context of each material. In the case of donation and use of blood, in particular, the issue of legitimate reimbursements to donors and for transfusion centers has to be managed in accordance with the principle of non-commercialization. There is also a need for strict rules to avoid possible commercial spillover effects from blood-derived products. The author proposes ethical criteria regarding reimbursements to donors, costs associated with processing, and the development (and possible marketing) of products.
KW - Bioethics
KW - Blood
KW - Europe
KW - Legislation
KW - Transfusion
UR - http://www.scopus.com/inward/record.url?scp=85034805483&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034805483&partnerID=8YFLogxK
U2 - 10.2147/JBM.S149417
DO - 10.2147/JBM.S149417
M3 - Article
AN - SCOPUS:85034805483
VL - 8
SP - 193
EP - 198
JO - Journal of Blood Medicine
JF - Journal of Blood Medicine
SN - 1179-2736
ER -